Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

PHASE3CompletedINTERVENTIONAL
Enrollment

897

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

January 19, 2024

Study Completion Date

January 19, 2024

Conditions
Migraine
Interventions
DRUG

Rimegepant 25 MG

Single dose of 25 mg orally disintegrating tablet of rimegepant

DRUG

Rimegepant 75 MG

Single dose of 75 mg orally disintegrating tablet of rimegepant

DRUG

Placebo

Matching placebo tablet

Trial Locations (50)

272-8513

Tokyo Dental College Ichikawa General Hospital, Ichikawa-shi

790-0925

Medical Corporation Seikokai Takanoko Hospital, Matsuyama

816-0802

Jinnouchi Neurosurgical Clinic, Kasuga-shi

816-0824

Ikeda Neurosurgical Clinic, Kasuga-shi

373-8585

SUBARU Health Insurance Society Ota Memorial Hospital, Ota-shi

730-0031

DOI CL Intern. Med./Neurol., Hiroshima

070-8530

Japanese Red Cross Asahikawa Hospital, Asahikawa-shi

003-0003

Higashi Sapporo Neurology and Neurosurgery Clinic, Sapporo

060-8570

Nakamura Memorial Hospital, Sapporo

658-0064

Konan Medical Center, Kobe

663-8014

Nishinomiya Municipal Central Hospital, Nishinomiya-shi

310-0015

Mito Kyodo General Hospital, Mito

929-0342

Kijima Neurosurgery Clinic, Kahoku-gun

020-8505

Iwate Med. Univ. Uchimaru MC, Morioka

892-0842

Atsuchi Neurosurgery Hospital, Kagoshima

892-0844

Tanaka Neurosurgical Clinic, Kagoshima

216-8511

St. Marianna Univ. Hospital, Kawasaki-shi

211-8588

Fujitsu Clinic, Nakahara

780-0051

Atago Hospital, Kochi

780-8011

Umenotsuji Clinic, Kochi

861- 4193

Saiseikai Kumamoto Hospital, Kumamoto

613-0034

Kyoto Okamoto Memorial Hospital, Kumiyama-cho

602-8566

University Hospital Kyoto Prefectural University of Medicine, Kyoto

606-0851

Ishikawa Clinic, Sakyo-ku

600-8811

Tatsuoka Neurology Clinic, Shimogyo-ku

981-3126

Narikawa Neurological Clinic, Izumi-ku

982-0014

Sendai Headache and Neurology Clinic, Medical Corporation, Sendai

870-0831

Ooba CL Neurosurg. & Headache, Ōita

700-0964

Makabe Clinic, Okayama

700-8557

Okayama City General Medical Center Okayama City Hospital, Okayama

556-0015

Tominaga Clinic, Naniwa-ku

530-8480

Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-kofukai, Osaka

589-8511

Kindai University Hospital, Osakasayama-shi

560-0012

Takase Intern. Med. Clinic, Toyonaka-shi

350-0495

Saitama Medical University Hospital, Iruma-gun

420-0853

JRC Shizuoka Hospital, Shizuoka

321-0293

Dokkyo Medical Univ. Hosp., Shimotsuga-gun

113-8431

Juntendo University Hospital, Bunkyo-ku

192-0032

Tokai university hachioji hospital, Hachioji-shi

108-0075

Shinagawa Strings Clinic, Minato-ku

108-8642

Kitasato University Kitasato Institute Hospital, Minato-ku

156-0043

USUDA CLINIC for internal medicine, Setagaya-ku

151-0051

Tokyo Headache Clinic, Shibuya-Ku

160-0017

Fukuuchi Pain Clinic, Shinjuku-ku

160-8582

Keio University Hospital, Shinjuku-ku

167-0054

Nishiogi Pain Clinic, Suginami-ku

190-0001

Suzuki Kei Yasuragi clinic, Tachikawa

930-0803

Sakura Neuro Clinic, Toyama

747-0802

Nagamitsu Clinic, Hofu-shi

400-0124

Nagaseki Headache Clinic, Kai-shi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05399459 - Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) | Biotech Hunter | Biotech Hunter